India races to release first indigenous Covid-19 vaccine by August 15 | Latest News India - Hindustan Times
close_game
close_game

India races to release first indigenous Covid-19 vaccine by August 15

Hindustan Times, New Delhi | Byhindutantimes.com | Edited by: Amit Chaturvedi
Jul 03, 2020 10:13 AM IST

The ICMR has asked these institutes to fast-track clinical trials of the vaccine as it is being considered as one of the “top priority projects”.

The Indian Council of Medical Research (ICMR) has partnered with Bharat Biotech International Limited (BBIL) for clinical trials of indigenous vaccine for the coronavirus disease.

The ICMR said that it is envisaged to launch the Covid-19 vaccine for public health use latest by August 15.(Representative Photo/Reuters)
The ICMR said that it is envisaged to launch the Covid-19 vaccine for public health use latest by August 15.(Representative Photo/Reuters)

BBIL is using the virus strain isolated at ICMR’s National Institute of Virology (NIV) in Pune to develop the vaccine.

Discover the thrill of cricket like never before, exclusively on HT. Explore now!

The clinical trials will be held in 12 institutes across the country. The ICMR has asked these institutes to fast-track clinical trials of the vaccine as it is being considered as one of the “top priority projects” which are being “monitored at the topmost level of the government”.

In a letter to these institutes, the ICMR said that it is envisaged to launch the vaccine for public health use latest by August 15, after completion of all clinical trials.

“BBIL is working expeditiously to meet the target, however, the final outcome will depend on the cooperation of all clinical trial sites involved in this project,” it further said in the letter.

It has also asked the institutes to ensure that the subject enrolment is initiated during the first week of July.

Apart from IMS and SUM Hospital here, the other institutes selected for the clinical trial are located in Visakhapatnam, Rohtak, New Delhi, Patna, Belgaum (Karnataka), Nagpur, Gorakhpur, Kattankulathur (Tamil Nadu), Hyderabad, Arya Nagar, Kanpur (Uttar Pradesh) and Goa.

Meanwhile, the Drug Controller General of India (DCGI) on Thursday granted permission to pharma giant Zydus Cadila to conduct phase I and phase II human clinical trials for Covid-19 vaccine.

The potential vaccine showed a “strong immune response” in animal studies, and the antibodies produced were able to completely neutralise the wild type virus, Zydus, part of Cadila Healthcare Ltd, said in a statement to Indian stock exchanges.

Zydus will begin human trials this month in over 1,000 subjects in multiple sites in India, it said.

Unveiling 'Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch Now!

Get Updates on India News alongwith the Latest News and Top Headlines from India and around the the world.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Monday, February 19, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On